SARS-CoV-2-Antikörper-Antwort auf die zweite COVID-19-Impfung bei neuromuskulären Patienten unter immunmodulierender Therapie

Successful vaccination (adequate elevation of anti-spike protein antibodies) is attributed with sufficient protection against a severe course of coronavirus disease 2019 (COVID-19). For patients with chronic inflammatory diseases (CID) and immunosuppression the success of vaccination is an ongoing s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosseini, S. S. Justus, Dudakova, Anna, Kummer, Karsten, Zschüntzsch, Jana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Originalien
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395911/
https://www.ncbi.nlm.nih.gov/pubmed/35997783
http://dx.doi.org/10.1007/s00115-022-01363-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395911/
https://www.ncbi.nlm.nih.gov/pubmed/35997783
http://dx.doi.org/10.1007/s00115-022-01363-6

Ejemplares similares